Key Takeaways VRTX gains EU approval for Alyftrek to treat CF patients aged six and above with non-class I mutations. Alyftrek offers once-daily dosing and potential benefits over Trikafta, including improved CFTR function. Alyftrek sales reached $53.9M in Q1 2025, with management expecting stronger uptake in H2 2025.Vertex Pharmaceuticals (VRTX) announced that the European Commission has approved Alyftrek (deutivacaftor/tezacaftor/vanzacaftor) for treating people with cystic fibrosis (“CF”) aged six year ...

Key Takeaways VRTX fell 8.9% over three months due to soft Q1 results and slower uptake of new and CF drugs. Alyftrek, Journavx, and Casgevy sales are expected to pick up in the second half of 2025. VRTX's CF franchise remains strong, with 2025 sales projected to grow 8% amid pipeline expansion.Vertex Pharmaceuticals Incorporated (VRTX) stock has declined 8.9% in the past three months.The deterioration was due to soft first-quarter results, slower-than-expected uptake of its newer drugs as well as CF drug ...

Extensive enhancements to tax technology portfolio empowers businesses with greater agility and accuracyKING OF PRUSSIA, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced a series of new certified integrations and solution enhancements that expand connectivity across ERP, e-commerce, procurement and financial systems. These updates reflect Vertex’s continued focus on simplifying and automating gl ...

As a long-time Oracle partner, Vertex will continue to leverage Oracle technologies to drive customer success globally KING OF PRUSSIA, June 10, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) ("Vertex" or the "Company"), a leading global provider of indirect tax solutions, today announced it has been selected to participate in Oracle's enhanced partner program at the highest level for Independent Software Vendors (ISVs). For more than 40 years, Oracle has been working closely with partners to help drive ...

At ELAM1, we empower financial professionals and investors with the scientific and clinical expertise required to navigate the complexities of the healthcare sector. By bridging the gap between cutting-edge science and financial strategy, we help our clients uncover hidden value, assess risks with greater accuracy, and make more informed investment decisions in life sciences. Feel free to reach us or to visit our website for more informations about us and our services.Analyst’s Disclosure: I/we have no stoc ...

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) was founded in 1989 and is based in Boston, MA. It is one of the world's leading biotechnology companies in the S&P 100 and has an approximate market capI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe the key to creating wealth is ...

Core Points - The United States District Court for the Southern District of Texas has approved a proposed class action settlement for purchasers of Vertex Energy, Inc. common stock [1][4] - The settlement amount is $6,300,000, which is subject to approval for fairness and adequacy [4] - A hearing is scheduled for July 30, 2025, to determine the approval of the settlement and the distribution plan [4] Settlement Class Details - The settlement class includes all individuals who purchased or acquired Vertex Energy, Inc. common stock from May 10, 2022, through August 8, 2022 [4][5] - A Proof of Claim must be submitted by June 20, 2025, to participate in the distribution of the settlement fund [5] - Members of the settlement class who do not request exclusion will be bound by the judgment in the consolidated actions [6] Legal and Administrative Information - The lead counsel for the plaintiffs is The Rosen Law Firm, P.A., and they are requesting attorneys' fees of up to one third of the settlement amount [4][7] - Objections to the settlement must be submitted by July 9, 2025 [7] - The court has instructed not to contact the court or clerk's office regarding this notice [8]

Vertex (VERX) FY Conference Summary Company Overview - Vertex has been operating for 47 years, initially focusing on sales and use tax in the US and evolving to handle all indirect taxes globally, including VAT [3][4] - The company serves approximately 60% of the Fortune 500 and has over 4,000 customers worldwide, addressing challenges in indirect tax compliance as companies expand into new geographies [4] Core Business Insights - **Pricing Model**: Vertex raises prices annually, typically realizing a 4% to 5% increase. Customers on three-year contracts may see larger increases upon renewal [6][7][8] - **Market Exposure**: Vertex operates across various sectors, including manufacturing, retail, technology, and oil and gas, providing a diversified revenue stream that mitigates risks from market anomalies [12] - **Product Mix**: The largest revenue source is sales and use tax determination, followed by VAT and compliance services. The company employs a "land and expand" strategy to increase wallet share over time [15][19] E-Invoicing Market Development - E-invoicing has become a regulatory requirement in many jurisdictions, initially gaining traction in Latin America and now expanding into Europe. Governments are adopting e-invoicing to close the VAT gap [27][30] - Vertex aims to be a global provider for e-invoicing, addressing the needs of multinationals that currently use multiple point solutions [30][31] - The company anticipates significant growth opportunities as more countries adopt e-invoicing regulations, with a focus on providing comprehensive solutions that integrate with existing systems [32][33] AI Integration and Opportunities - Vertex views AI as a tool to enhance its offerings but does not see it as a threat to its value proposition due to the unique manual processes involved in tax compliance [42][47] - The company has launched AI-driven features like SmartCat to improve product categorization, which is crucial for accurate tax determination [48][49] Financial Performance and Growth Drivers - Vertex targets over 20% growth in software subscriptions and aims for high EBITDA margins, with a focus on leveraging investments made in recent years [83][84] - Key growth drivers include the ongoing migration to cloud-based ERP systems and the expansion of e-invoicing capabilities [86][88] - The company expects to see improved EBITDA margins as it moves past its current investment phase, with projections of around 21% for 2025 [93] Competitive Landscape - Vertex differentiates itself through its extensive tax content library, strong relationships with major accounting firms, and the ability to integrate multiple systems into a cohesive tax solution [78][81] - The company emphasizes the importance of referenceability and the ability to customize solutions for complex enterprise needs [81][82] Conclusion - Vertex is well-positioned for growth in the evolving landscape of tax compliance, particularly with the increasing regulatory focus on e-invoicing and the migration to cloud-based solutions. The company's strategic investments and diversified product offerings are expected to drive future performance and profitability [98][99]

Company Overview - Vertex, Inc. is a leading global provider of indirect tax solutions, focusing on delivering trusted tax technology for global businesses to transact, comply, and grow with confidence [3] - The company offers tailored solutions for major lines of indirect tax, including sales and consumer use, value added, and payroll [3] - Vertex is headquartered in North America, with additional offices in South America and Europe, aiming to simplify the complexity of continuous compliance for leading brands [3] Upcoming Events - David DeStefano, CEO, and John Schwab, CFO of Vertex, will participate in a fireside chat at the 20th Annual Needham Technology, Media, & Consumer Conference [1] - The event is scheduled for May 12, 2025, at 9:30 AM Eastern Time [1] - Live webcasts and replays of the presentations will be available on Vertex's investor relations website [2]

Financial Performance - Vertex generated revenue of $177.1 million for the three months ended March 31, 2025, representing a 12.8% increase from $156.8 million in the same period of 2024[114]. - Net income for Vertex was $11.1 million for the three months ended March 31, 2025, compared to $2.7 million for the same period in 2024, indicating a significant improvement[114]. - Adjusted EBITDA was $37.2 million for the three months ended March 31, 2025, slightly up from $36.7 million in the same period of 2024[115]. - Total revenues increased by $20.3 million, or 12.9%, to $177.1 million for the three months ended March 31, 2025, compared to $156.8 million for the same period in 2024[151]. - Software subscriptions revenues rose by $18.9 million, or 14.4%, driven by existing customer growth and price increases[151]. - Net income for the three months ended March 31, 2025, was $11.1 million, compared to $2.7 million for the same period in 2024, representing a 314.7% increase[144]. - Total comprehensive income for the period was $26.2 million, compared to a loss of $1.3 million in the prior year, marking a significant turnaround[144]. - Non-GAAP gross profit increased to $132.8 million for the three months ended March 31, 2025, compared to $113.7 million in 2024[203]. - Non-GAAP gross margin improved to 75.0% for the three months ended March 31, 2025, from 72.5% in 2024[203]. - Non-GAAP net income increased to $24,494 thousand in Q1 2025 from $23,431 thousand in Q1 2024, reflecting a growth of 4.5%[204]. Revenue Streams - Cloud-based subscription revenue accounted for 53% of total software subscription revenue in Q1 2025, up from 47% in Q1 2024, highlighting a shift towards cloud deployment[110]. - Vertex expects continued growth in cloud-based subscription sales, which have been growing at a faster rate than on-premise sales[110]. - Annual Recurring Revenue (ARR) increased by $94.0 million, or 17.9%, to $618.5 million as of March 31, 2025, compared to $524.5 million in 2024[185]. - Average Annual Revenue Per Customer (AARPC) increased to approximately $126,534 as of March 31, 2025, compared to $121,720 in 2024[186]. Expenses and Costs - Research and development expenses are expected to increase in absolute dollars as Vertex continues to enhance its product offerings and integrate new technologies[131]. - Cost of software subscriptions revenues decreased by $0.9 million, or 2.0%, to $44.2 million for the three months ended March 31, 2025[153]. - Cost of services revenues increased by $4.0 million, or 25.0%, to $19.8 million, driven by higher service delivery personnel costs[154]. - Research and development expenses increased by $4.0 million, or 24.0%, to $20.9 million, reflecting investments in new solutions and AI-related initiatives[155]. - Selling and marketing expenses rose by $7.7 million, or 18.9%, to $48.2 million, primarily due to increased payroll and advertising expenses[156]. - General and administrative expenses increased by $9.5 million, or 26.7%, to $45.0 million, driven by strategic investments in IT infrastructure and business processes[157]. Cash Flow and Liquidity - Net cash provided by operating activities decreased by 39.7% to $14.8 million for the three months ended March 31, 2025, compared to $24.6 million in 2024[168]. - Net cash used in financing activities increased significantly to $20.7 million for the three months ended March 31, 2025, compared to $1.2 million in 2024[174]. - As of March 31, 2025, the company had unrestricted cash and cash equivalents of $270.4 million and a $300.0 million Line of Credit with no outstanding borrowings[165]. - Operating cash flow decreased to $14.8 million for the three months ended March 31, 2025, down from $24.6 million in 2024[195]. Investment and Strategic Initiatives - Vertex completed a strategic investment of $15.0 million in Kintsugi AI, Inc., acquiring a 10% ownership interest to enhance its sales tax compliance solutions[116]. - The company plans to invest $10.0 to $12.0 million in AI technologies during 2025, separate from the Kintsugi investment[116]. - Vertex's flexible pricing model allows customers to increase spending as they grow, providing sustainable organic growth opportunities[109]. - Vertex's partner ecosystem includes major technology firms like Microsoft, Oracle, and Salesforce, enhancing its competitive strength in the market[111]. Market Metrics - Net Revenue Retention Rate (NRR) decreased to 109% for the three months ended March 31, 2025, down from 112% in 2024[188]. - Gross Revenue Retention Rate (GRR) remained stable at 95% for both March 31, 2025, and 2024[190]. - Adjusted EBITDA margin decreased to 21.0% for the three months ended March 31, 2025, from 23.4% in 2024, primarily due to strategic investments[193]. - Free cash flow decreased by $16.8 million to $(12.3) million for the three months ended March 31, 2025, compared to $4.5 million in 2024[196]. - Free cash flow margin decreased to (6.9)% for the three months ended March 31, 2025, from 2.9% in 2024[196]. Risk Factors - Approximately 4% of the company's revenues for both Q1 2025 and Q1 2024 were denominated in currencies other than U.S. Dollars, indicating exposure to foreign currency exchange risk[211]. - The company is exposed to interest rate risk on outstanding borrowings, which bear variable interest rates[209]. - The fair value of fixed-rate debt instruments may fluctuate with changes in interest rates, although the company carries the Notes at principal value[210]. - The company may hedge selected significant transactions denominated in currencies other than the U.S. dollar as it expands international operations[212].